Progesterone treatment increased VEGF and EGFR levels in astrocytoma by acting on PR, and knockdown of SRC-1 significantly reduced VEGF expression but had no significant effect on EGFR [91]. This evidence concerns the gene NCOA1 and astrocytoma (excluding glioblastoma).